InvestorsHub Logo
Followers 5
Posts 809
Boards Moderated 0
Alias Born 08/30/2017

Re: peterus post# 1581

Thursday, 07/09/2020 1:56:38 PM

Thursday, July 09, 2020 1:56:38 PM

Post# of 1739
We are going up much higher this month now that the Markets and shareholders know Evoke Pharma is planning on bring Gimoti nasal spray drug to treat Diabetic Gastroparesis to the commercial prescription sale Market. Up to $4 billion dollar annual prescription in sales to treat the symptoms caused by Diabetic Gastroparesis, that is triggered by Diabetes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVOK News